134 related articles for article (PubMed ID: 3018201)
1. Severe systemic reaction to diphosphonate bone imaging agents: skin testing to predict allergic response and a safe alternative agent.
Ramos-Gabatin A; Orzel JA; Maloney TR; Murnane JE; Borchert RD
J Nucl Med; 1986 Sep; 27(9):1432-5. PubMed ID: 3018201
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
4. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
Armas R; Neumann R; Goldsmith SJ
J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
[TBL] [Abstract][Full Text] [Related]
5. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
6. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
7. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
Tan KF; Chang CH
Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
[No Abstract] [Full Text] [Related]
8. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
Clouet M; Chavoin JP; Vigoni F; Pessey JJ; Costagliola M
Ann Chir Plast; 1981; 26(3):217-20. PubMed ID: 6458230
[No Abstract] [Full Text] [Related]
9. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors].
Okuyama T; Suzuki H; Nakamoto K; Suzuki S
Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357
[No Abstract] [Full Text] [Related]
10. Effects of renal failure and metabolic diseases upon bone scanning in children.
Schümichen C
Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
[No Abstract] [Full Text] [Related]
11. Optimizing the performance and interpretation of bone scans.
Muroff LR
Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
[No Abstract] [Full Text] [Related]
12. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent].
Ishine M; Kawamura M; Koizumi M; Itoh H; Murase K; Inatsuki S; Iio A; Hamamoto K
Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):389-97. PubMed ID: 6214765
[No Abstract] [Full Text] [Related]
13. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
14. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
[No Abstract] [Full Text] [Related]
15. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
[No Abstract] [Full Text] [Related]
16. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
[No Abstract] [Full Text] [Related]
17. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
[No Abstract] [Full Text] [Related]
18. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
19. [An experimental crossover study between hydroxymethylene diphosphonate kit and methylene diphosphonate (author's transl)].
Nagai K; Muranaka A; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Ito Y
Radioisotopes; 1982 Jan; 31(1):32-4. PubMed ID: 6461888
[No Abstract] [Full Text] [Related]
20. The technetium phosphate bone scan in the diagnosis of osteomyelitis in childhood.
Howie DW; Savage JP; Wilson TG; Paterson D
J Bone Joint Surg Am; 1983 Apr; 65(4):431-7. PubMed ID: 6300132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
